REQUEST A DEMO
Total
USD $0.00
Search more companies

Biofarm SA (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biofarm SA Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Biofarm SA is among the largest manufacturers of medicines in Romania, operating in the field since 1921. Currently, the company has in its portfolio over 100 products covering over 60 therapeutic areas. Biofarm SA is already present in 12 countries in Europe and Asia and plans to expand its presence in other markets as well. Since 2018, export represents over 4% of the company's sales. Biofarm SA is listed on the Bucharest Stock Exchange under the stock symbol BIO.

Headquarters
Strada Logofatul Tautu Nr. 99
Bucharest; Bucharest; Postal Code: 031212

Contact Details: Purchase the Biofarm SA report to view the information.

Website: http://www.biofarm.ro

Basic Information
Total Employees:
Purchase the Biofarm SA report to view the information.
Outstanding Shares:
Purchase the Biofarm SA report to view the information.
Registered Capital:
Purchase the Biofarm SA report to view the information.
Financial Auditors:
Purchase the Biofarm SA report to view the information.
Incorporation Date:
February 05, 1991
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
51.5774%
Purchase this report to view the information.
36.7471%
Company Performance
Financial values in the chart are available after Biofarm SA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-12.95%
Total operating revenue
-12.85%
Operating profit (EBIT)
-13.26%
EBITDA
-11.27%
Net Profit (Loss) for the Period
-16.21%
Total assets
5.97%
Total equity
11.29%
Operating Profit Margin (ROS)
-0.12%
Net Profit Margin
-1.15%
Return on Equity (ROE)
-3.09%
Debt to Equity Ratio
-0.01%
Quick Ratio
0.5%
Cash Ratio
-0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?